Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
31678 | 149 | 46.9 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
296 | 3 | BREAST//BREAST CANCER//LYMPHEDEMA | 41323 |
2107 | 2 | LYMPHANGIOGENESIS//VEGF C//PODOPLANIN | 5136 |
31678 | 1 | ENDMT//ENDOTHELIAL MESENCHYMAL TRANSITION//ENDOTHELIAL TO MESENCHYMAL TRANSITION | 149 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ENDMT | authKW | 1255220 | 9% | 44% | 14 |
2 | ENDOTHELIAL MESENCHYMAL TRANSITION | authKW | 1249117 | 11% | 38% | 16 |
3 | ENDOTHELIAL TO MESENCHYMAL TRANSITION | authKW | 1165840 | 11% | 36% | 16 |
4 | ENDOMT | authKW | 614803 | 4% | 50% | 6 |
5 | SERV AUTONOMO BIOMED | address | 307402 | 2% | 50% | 3 |
6 | CARDIAC ENDMT | authKW | 204936 | 1% | 100% | 1 |
7 | CELLULAR PHENOTYPE TRANSFORMATION | authKW | 204936 | 1% | 100% | 1 |
8 | DERMOPATOL | address | 204936 | 1% | 100% | 1 |
9 | DIABETIC RENAL FIBROSIS | authKW | 204936 | 1% | 100% | 1 |
10 | ENDMT TRANSFORMED CELLS | authKW | 204936 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 592 | 33% | 0% | 49 |
2 | Cell & Tissue Engineering | 369 | 5% | 0% | 7 |
3 | Cardiac & Cardiovascular System | 202 | 15% | 0% | 23 |
4 | Peripheral Vascular Diseases | 133 | 9% | 0% | 14 |
5 | Medicine, Research & Experimental | 88 | 10% | 0% | 15 |
6 | Pathology | 86 | 7% | 0% | 11 |
7 | Biochemistry & Molecular Biology | 48 | 19% | 0% | 28 |
8 | Urology & Nephrology | 28 | 5% | 0% | 7 |
9 | Rheumatology | 26 | 3% | 0% | 4 |
10 | Physiology | 24 | 5% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SERV AUTONOMO BIOMED | 307402 | 2% | 50% | 3 |
2 | DERMOPATOL | 204936 | 1% | 100% | 1 |
3 | GEN PHATOL UNIT | 204936 | 1% | 100% | 1 |
4 | GEORGE E WAHLEN VAMC | 204936 | 1% | 100% | 1 |
5 | HLTH CARE IRCCS | 204936 | 1% | 100% | 1 |
6 | IND MICROBIOLMINIST EDUC TIANJIN CITY | 204936 | 1% | 100% | 1 |
7 | JEFFERSON STEIN CELL BIOL REGENERAT MED | 204936 | 1% | 100% | 1 |
8 | MICROBIOL IMMUNOL CANC CELL BIOL | 204936 | 1% | 100% | 1 |
9 | ORAL PATHOLCELLULAR MOL PATHOL UNIT | 204936 | 1% | 100% | 1 |
10 | PAEAN BIOTECHNOL | 204936 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | REVISTA LATINOAMERICANA DE HIPERTENSION | 2089 | 1% | 1% | 1 |
2 | CARDIOVASCULAR DIABETOLOGY | 1487 | 2% | 0% | 3 |
3 | BIOLOGICAL PROCEDURES ONLINE | 1329 | 1% | 1% | 1 |
4 | BMC CELL BIOLOGY | 1028 | 1% | 0% | 2 |
5 | STEM CELLS INTERNATIONAL | 827 | 1% | 0% | 2 |
6 | ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH | 621 | 1% | 0% | 1 |
7 | MEDIATORS OF INFLAMMATION | 594 | 2% | 0% | 3 |
8 | AMERICAN JOURNAL OF PATHOLOGY | 577 | 4% | 0% | 6 |
9 | TISSUE ENGINEERING PART B-REVIEWS | 564 | 1% | 0% | 1 |
10 | CELLULAR REPROGRAMMING | 529 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PINTO, MT , COVAS, DT , KASHIMA, S , RODRIGUES, CO , (2016) ENDOTHELIAL MESENCHYMAL TRANSITION: COMPARATIVE ANALYSIS OF DIFFERENT INDUCTION METHODS.BIOLOGICAL PROCEDURES ONLINE. VOL. 18. ISSUE . P. - | 21 | 64% | 2 |
2 | MEDICI, D , (2016) ENDOTHELIAL-MESENCHYMAL TRANSITION IN REGENERATIVE MEDICINE.STEM CELLS INTERNATIONAL. VOL. . ISSUE . P. - | 35 | 41% | 0 |
3 | CORREIA, ACP , MOONEN, JRAJ , BRINKER, MGL , KRENNING, G , (2016) FGF2 INHIBITS ENDOTHELIAL-MESENCHYMAL TRANSITION THROUGH MICRORNA-20A-MEDIATED REPRESSION OF CANONICAL TGF-BETA SIGNALING.JOURNAL OF CELL SCIENCE. VOL. 129. ISSUE 3. P. 569 -579 | 20 | 42% | 7 |
4 | LAO, KH , ZENG, LF , XU, QB , (2015) ENDOTHELIAL AND SMOOTH MUSCLE CELL TRANSFORMATION IN ATHEROSCLEROSIS.CURRENT OPINION IN LIPIDOLOGY. VOL. 26. ISSUE 5. P. 449 -456 | 22 | 34% | 6 |
5 | YU, WJ , LIU, Z , AN, S , ZHAO, JY , XIAO, L , GOU, YC , LIN, YF , WANG, J , (2014) THE ENDOTHELIAL-MESENCHYMAL TRANSITION (ENDMT) AND TISSUE REGENERATION.CURRENT STEM CELL RESEARCH & THERAPY. VOL. 9. ISSUE 3. P. 196-204 | 22 | 33% | 11 |
6 | ZHANG, JJ , YOU, Y , LI, Y , GUI, QJ , FENG, JL , YIN, K , (2015) RESEARCH ADVANCES OF THE ENDOTHELIAL-TO-MESENCHYMAL TRANSITION AND CARDIOVASCULAR DISEASE.PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. VOL. 42. ISSUE 7. P. 606 -615 | 23 | 34% | 0 |
7 | XIAO, L , DUDLEY, AC , (2017) FINE-TUNING VASCULAR FATE DURING ENDOTHELIAL-MESENCHYMAL TRANSITION.JOURNAL OF PATHOLOGY. VOL. 241. ISSUE 1. P. 25 -35 | 25 | 24% | 0 |
8 | MUYLAERT, DEP , DE JONG, OG , SLAATS, GGG , NIEUWEBOER, FE , FLEDDERUS, JO , GOUMANS, MJ , HIERCK, BP , VERHAAR, MC , (2016) ENVIRONMENTAL INFLUENCES ON ENDOTHELIAL TO MESENCHYMAL TRANSITION IN DEVELOPING IMPLANTED CARDIOVASCULAR TISSUE-ENGINEERED GRAFTS.TISSUE ENGINEERING PART B-REVIEWS. VOL. 22. ISSUE 1. P. 58 -67 | 24 | 23% | 1 |
9 | WERMUTH, PJ , LI, ZD , MENDOZA, FA , JIMENEZ, SA , (2016) STIMULATION OF TRANSFORMING GROWTH FACTOR-BETA 1-INDUCED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION AND TISSUE FIBROSIS BY ENDOTHELIN-1 (ET-1): A NOVEL PROFIBROTIC EFFECT OF ET-1.PLOS ONE. VOL. 11. ISSUE 9. P. - | 17 | 31% | 0 |
10 | ZHANG, Y , WU, XX , LI, Y , ZHANG, HY , LI, ZG , ZHANG, Y , ZHANG, LY , JU, JM , LIU, X , CHEN, XH , ET AL (2016) ENDOTHELIAL TO MESENCHYMAL TRANSITION CONTRIBUTES TO ARSENIC-TRIOXIDE-INDUCED CARDIAC FIBROSIS.SCIENTIFIC REPORTS. VOL. 6. ISSUE . P. - | 15 | 33% | 0 |
Classes with closest relation at Level 1 |